|
Leader of the study project TP0: Patient register
Gisela Antony
phone: ++49 6421 5865440
email: gisela.antony@med.uni-marburg.de
Leader of the study project TP6: Multi-center studies
PD Dr. med. Karla Eggert
phone: ++49 6421 5865443
email: eggert@med.uni-marburg.de
Leader of the study projekt TP8:
Economic aspects of the idiopathic Parkinson Syndrome
Prof. Dr. med. Richard Dodel
Tel: ++49 6421 5866251
E-Mail: richard.dodel@staff.uni-marburg.de
Contact person for the study projekt TP1: Gene Bank GEPARD
Dr. Carsten Müller
phone: ++49 6421 5865338
email: moellerc@staff.uni-marburg.de
Role of the institution in the Competence Network on Parkinson’s disease
The Central Coordination Center at the Department Of Neurology, Philipps-University in Marburg is one of the five coordination centers in the Competence Network on Parkinson’s disease and is also the headquarter of the network office. It coordinates the activities of the regional centers Göttingen, Kassel, Hanau, Heidelberg, Bad Nauheim and Lemgo, which comprise the horizontal part of the network. Additionally, it has responsibility for running the vertical network. Contacts to local neurologists will be established at an early stage. The Central Coordination Center runs project 6 (Multi-center therapy study, managed by Marburg). We will also take an active role in projects 1 and 3.
Description of the institution
Clinic:
The Department of Neurology deals with a wide range of neurological diseases. Specialist fields include: movement disorders (Parkinson's disease, dystonia, restless-leg-syndrome), epilepsy, pain therapy, neuro-immunological diseases including multiple sclerosis, neuromuscular diseases (Muscle-Center Marburg-Gießen) as well as neurovascular disorders (including a stroke unit). In each of these fields we have outpatient clinics.
Research:
The Movement Disorders Research group works on neuroprotective substances and neurotransplantation in animal models of the idiopathic Parkinson disease. The Clinical Movement Disorders is working as part in a number of national and international co-operations developing imaging techniques for the discrimination of different Parkinsonian syndromes and is investigating the therapeutic possibilities of deep brain stimulation and cell transplantation in Parkinson's disease. Research is being undertaken in insomnia in basal ganglia diseases and several multi-center studies of new anti-Parkinson drugs are being coordinated. The significance of neurotrophic factors for neuroprotection and synaptic plasticity is being investigated using neuronal cells and the possible mechanisms involved in neurodegenerative diseases (neurogenetics, apoptosis) are being investigated. The Botulinum toxin group is researching new applications of the botulinum toxin A-therapy. In the Restless-legs-syndrome group, research on the pathophysiology and therapy of this disease is being conducted.
Further information
in the internet
www.med.uni-marburg.de/neurol/
|
